| Transferring research to policymakers | Transferring research to providers organizations | ||
---|---|---|---|---|
 | Beta†(Standard Error) | P-Value | Beta (Standard Error) | P-Value |
Constant | 0.368 (0.493) | 0.457 | 0.364 (0.493) | 0.505 |
Frequency of undertaking each of these knowledge transfer and exchange activities related to contact and exchange with health policymakers and stakeholders | Â | Â | Â | Â |
   1- Interacted with credible messengers/sources (i.e., people who are not researchers but are seen by policymakers and stakeholders as credible sources of research) to promote use of evidence from HPSR and/or your own research | -0.022 (0.081) | 0.817 | 0.127 (0.089) | 0.229 |
   2- Developed relationships with print, radio and/or television journalists to promote use of evidence from HPSR and/or your own research. | 0.229 (0.091) | 0.026 | -0.168 (0.101) | 0.142 |
   3- Participated in meetings for presentation of results from HPSR and/or your own research to health policymakers and stakeholders. | -0.027 (0.091) | 0.805 | 0.008 (0.100) | 0.946 |
   4- Tried to involve policymakers and stakeholders but had difficulty contacting them. | -0.033 (0.068) | 0.699 | 0.301 (0.075) | 0.002 |
   5- Provided technical assistance to policymakers and stakeholders through short-term work through expert advisory committees, conferences, or forums. | 0.03 (0.106) | 0.819 | -0.402 (0.116) | 0.008 |
   6- Provided technical assistance through long-term formal collaborations between your institution and policymakers and stakeholders for sustained technical capacity development. | 0.012 (0.111) | 0.931 | 0.296 (0.122) | 0.056 |
   7- Interacted with health policymakers and stakeholders through informal conversations with personal contacts. | 0.056 (0.091) | 0.584 | -0.007 (0.100) | 0.948 |
   8- Interacted with health policymakers and stakeholders as part of a priority-setting process to identify high-priority health policy issues and research themes. | 0.196 (0.118) | 0.144 | 0.114 (0.13) | 0.446 |
   9- Involved policymakers and stakeholders in your research (in the development of joint proposals/research methodology and tools/analysis & write-up/publications). | 0.314 (0.091) | 0.004 | 0.314 (0.100) | 0.01 |
   10- Actively participated in health policy development committees or technical committees that help in decisionmaking. | 0.079 (0.084) | 0.447 | 0.103 (0.092) | 0.38 |
   11- Trained health policymakers and stakeholders to acquire, assess, interpret, and apply health research findings. | 0.025 (0.081) | 0.799 | 0.106 (0.089) | 0.345 |
Investments/resources available to you for the production and transfer and exchange of evidence from HPSR | Â | Â | Â | Â |
   1. National funding is available for undertaking HPSR. | -0.062 (0.091) | 0.554 | 0.178 (0.100) | 0.133 |
   2- Regional funding is available for undertaking HPSR. | -0.066 (0.103) | 0.539 | 0.00 (0.113) | 0.998 |
   3- International funding is available for undertaking HPSR. | 0.346 (0.105) | 0.001 | -0.131 (0.116) | 0.239 |
   4- Funding sources (e.g., granting agencies) encourage knowledge transfer and exchange activities. | 0.021 (0.084) | 0.801 | 0.203 (0.093) | 0.028 |
   5- Funders formulate their priorities and calls for proposals in response to national and regional needs. | 0.011 (0.089) | 0.91 | -0.003 (0.098) | 0.977 |
   6- Policymakers and stakeholders provide adequate funding for priority research. | 0.068 (0.093) | 0.487 | 0.037 (0.102) | 0.739 |
   7- Policymakers and stakeholders clearly articulate priorities for health systems and policy research. | -0.198 (0.108) | 0.078 | 0.03 (0.119) | 0.81 |
   8- Incentives for knowledge transfer and exchange are available (e.g., performance incentives for knowledge transfer and exchange and proper criteria of promotion) within your organization. | -0.036 (0.077) | 0.655 | -0.028 (0.085) | 0.755 |
Adjusted R2 | 0.465 | Â | 0.331 | Â |
F | 6.030 | Â | 3.8585 | Â |
P-value | < 0.001 | Â | < 0.001 | Â |
N | 110 | Â | 110 | Â |